Skip to content

40 mg

DRUG4 trials

Sponsors

Region Skane, Region Skane, Turku University Hospital, Medical University Of Bialystok, Instytut Hematologii I Transfuzjologii

Conditions

Bladder cancerChronic obstructive pulmonary disease (COPD)Diffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCLDiffuse large B-cell lymphomas (DLBCLHigh-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiationPrimary or recurrent non-muscle invasive bladder cancer with intermediate risk of recurrence after transurethral tumour resection

Phase 2

Phase 3